Melatonin protects against sarcopenia in middle-aged mice

• Fei Fang ^[1] ; Ping Yu ^[1] ; Xiaoying Sun ^[1] ; Zhixing Shen ^[1] ; Fan Zhang ^[1] ; Jianwei Sun ^[2]
  1. [1] Huzhou Third Municipal Hospital, The Affiliated Hospital of Huzhou University, PR China
  2. [2] First Affiliated Hospital of Huzhou University, The First People's Hospital of Huzhou, Huzhou City, Zhejiang Province, PR China
• Localización: Histology and histopathology: cellular and molecular biology, ISSN-e 1699-5848, ISSN 0213-3911, Vol. 40, Nº. 5, 2025, págs. 745-755
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Background. Sarcopenia is a common agerelated disease. Melatonin (MEL) is an age-related endocrine hormone, which displays a crucial role in resisting oxidative stress during aging. Importantly, the antioxidant properties of MEL can be mediated by mitochondria.

    Objective. Therefore, we wondered whether MEL could mitigate oxidative stress caused by mitochondria in sarcopenia.

    Methods. The middle-aged mice were administered 5 mg/kg/d and 10 mg/kg/d of MEL for 2 months. Young mice were used as the control group.

    Results. After treatment with MEL, the grip strength of the fore/hind limbs, running time, and distance were elevated, and the weights of the gastrocnemius (GA), tibialis anterior (TA), extensor digitorum longus (EDL), and soleus (SOL) were enhanced in middle-aged mice.

    Additionally, MEL was observed to alleviate histological damage and increase the cross-sectional area of muscle fibers in GA tissues of middle-aged mice. Furthermore, following MEL treatment, there was an increase in the percentage and size of normal mitochondria as well as mtDNA copy number but a reduction in the levels of malondialdehyde (MDA), protein carbonyl, and reactive oxygen species (ROS) in the GA tissues of middle-aged mice. At the molecular level, MEL repressed the levels of ATROGIN-1, muscle RING-finger protein-1 (MURF1), and the ratio of p-P38/P38, but elevated the expression of cytochrome c oxidase subunit 4 (COX4), cystatin C (CYTC), nuclear respiratory factor 1 (NRF1), mitochondrial transcription factor A (TFAM), and peroxisome proliferator-activated receptor γ coactivator1α (PGC-1α) in the GA tissues of middle-aged mice.

    Importantly, 10 mg/kg MEL was more efficacious in the treatment of sarcopenia than 5 mg/kg MEL.

    Conclusion. MEL attenuates sarcopenia in middleaged mice, and the mechanism may relate to mitochondria-induced oxidative stress and the PGC1α/TFAM pathway.